Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

O. Clegg, Daniel; J. Reda, Domenic; Mejías, Edwin; W. Cannon, Grant; H. Weisman, Michael; H. Taylor, Thomas; Budiman‐Mak, Elly; D. Blackburn, Warren; B. Vasey, Frank; L. Mahowald, Maren; J. Cush, John; Ralph Schumacher, H.; L. Silverman, Stuart; Paul Alepa, F.; E. Luggen, Michael; R. Cohen, Miriam; Makkena, Rama; Haakenson, Clair; H. Ward, Richard; Manaster, B.J.; J. Anderson, Robert; Ward, John; G. Henderson, William

doi:10.1002/art.1780391210

Public

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

Published in Arthritis & Rheumatism • Dec 1, 1996

Authors:

Daniel O. Clegg

Domenic J. Reda

Edwin Mejías

Abstract

OBJECTIVE: To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory drug therapy. METHODS: Two hundred twenty-one patients with PsA were recruited from 15 clinics, randomized (do...

Subject

Medicine

Psoriatic arthritis

Sulfasalazine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!